Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CANDESARTAN | 32MG | TABLET | Resolved | 2017-03-20 | 2020-02-25 | 3516 |
APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Resolved | 2017-03-20 | 2019-01-03 | 3520 |
APO-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-20 | 2017-07-11 | 3529 |
APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-03-20 | 2017-04-24 | 3533 |
APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2017-03-20 | 2017-03-24 | 3539 |
APO-CIPROFLOX | 500MG | TABLET | Resolved | 2017-03-20 | 2017-06-12 | 3619 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Resolved | 2017-03-20 | 2017-05-02 | 3622 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-03-21 | 2017-03-21 | 3746 |
APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2017-03-21 | 2017-04-14 | 3800 |
APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2017-03-22 | 2017-05-02 | 3909 |
APO-MIDODRINE | 5.0MG | TABLET | Resolved | 2017-03-28 | 2017-04-14 | 4521 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-04-04 | 2017-04-25 | 5366 |
APO-DONEPEZIL | 5MG | TABLET | Resolved | 2017-04-04 | 2017-07-24 | 5402 |
APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-04-07 | 2018-11-30 | 5865 |
APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2017-04-07 | 2017-12-11 | 5888 |
APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2017-04-07 | 2017-06-27 | 5891 |
APO-GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-04-07 | 2017-09-15 | 5897 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2017-04-07 | 2017-05-18 | 5997 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-04-07 | 2017-06-09 | 6000 |
APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Resolved | 2017-04-11 | 2018-12-20 | 6414 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |